Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020.

Autor: Brown NE; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Lyons AK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Schuh AJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Stumpf MM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Harcourt JL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Tamin A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Rasheed MAU; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Mills L; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Lester SN; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Thornburg NJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Nguyen K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Costantini V; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Vinjé J; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Huang JY; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Gilbert SE; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Gable P; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Bollinger S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Sabour S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Beshearse E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Surie D; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Biedron C; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Gregory CJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Clemmons NS; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Whitaker B; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Coughlin MM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Seely KA; Arkansas Department of Health, Little Rock, Arkansas., Garner K; Arkansas Department of Health, Little Rock, Arkansas., Gulley T; Arkansas Department of Health, Little Rock, Arkansas., Haney T; Arkansas Department of Health, Little Rock, Arkansas., Kothari A; Arkansas Department of Health, Little Rock, Arkansas., Patil N; Arkansas Department of Health, Little Rock, Arkansas., Halpin AL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., McDonald LC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Kutty PK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Brown AC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2022 Nov; Vol. 43 (11), pp. 1610-1617. Date of Electronic Publication: 2021 Nov 22.

Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.

Autor: Costantini VP; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA; vcostantini@cdc.gov., Nguyen K; Oak Ridge Institute for Science and Education, Oak Ridge, TN., Lyski Z; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR., Novosad S; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Bardossy AC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Lyons AK; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Gable P; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Kutty PK; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Lutgring JD; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Brunton A; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR., Thornburg NJ; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Brown AC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., McDonald LC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA., Messer W; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR.; School of Public Health, Oregon Health & Science University, Portland, OR; and.; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, OR., Vinjé J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Mar 15; Vol. 208 (6), pp. 1500-1508. Date of Electronic Publication: 2022 Feb 28.

Factors influencing environmental sampling recovery of healthcare pathogens from non-porous surfaces with cellulose sponges.

Autor: Rose LJ; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Houston H; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Martinez-Smith M; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Lyons AK; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Whitworth C; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Reddy SC; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Noble-Wang J; Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261588. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).

Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG.

Autor: Costantini VP; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Nguyen K; Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37830., Lyski Z; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA., Novosad S; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Bardossy AC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Lyons AK; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Gable P; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Kutty PK; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Lutgring JD; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Brunton A; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA., Thornburg N; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Brown AC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., McDonald LC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Messer W; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.; School of Public Health, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, OR 97239, USA., Vinjé J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Sep 07. Date of Electronic Publication: 2021 Sep 07.

Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents-Arkansas, June-August 2020.

Autor: Surie D; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Huang JY; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Brown AC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gable P; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Biedron C; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gilbert SE; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Garner K; Arkansas Department of Health, Little Rock, Arkansas, USA., Bollinger S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gulley T; Arkansas Department of Health, Little Rock, Arkansas, USA., Haney T; Arkansas Department of Health, Little Rock, Arkansas, USA., Lyons AK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Beshearse E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gregory CJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sabour S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Clemmons NS; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., James AE; Arkansas Department of Health, Little Rock, Arkansas, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tamin A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Reese N; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Perry-Dow KA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Brown R; Arkansas Department of Health, Little Rock, Arkansas, USA., Harcourt JL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Campbell D; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Houston H; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chakravorty R; Arkansas Department of Health, Little Rock, Arkansas, USA., Paulick A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitaker B; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Murdoch J; Arkansas Department of Health, Little Rock, Arkansas, USA., Spicer L; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stumpf MM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mills L; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Coughlin MM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Higdem P; Arkansas Department of Health, Little Rock, Arkansas, USA., Rasheed MAU; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lonsway D; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bhatnagar A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kothari A; Arkansas Department of Health, Little Rock, Arkansas, USA., Anderson K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Thornburg NJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Breaker E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adamczyk M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McAllister GA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Halpin AL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Seely KA; Arkansas Department of Health, Little Rock, Arkansas, USA., Patil N; Arkansas Department of Health, Little Rock, Arkansas, USA., McDonald LC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kutty PK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Jan 30; Vol. 8 (3), pp. ofab048. Date of Electronic Publication: 2021 Jan 30 (Print Publication: 2021).